All drugs.

Search drugs by brand or generic name, or refine the directory by prescription status, class, indication, manufacturer, and specialty.

Advertisement

Enter at least 3 characters to search the full directory.

Results

Showing 1–19 of 19 drugs · filtered

AVASTIN (bevacizumab)

VASCULAR ENDOTHELIAL GROWTH FACTOR(VEGF) MONOCLONAL ANTIBODY · METASTATIC COLORECTAL CANCER ·+6
GENENTECH

AFINITOR (everolimus)

ANTINEOPLASTIC - MTOR KINASE INHIBITORS · METASTATIC RENAL CELL CARCINOMA ·+6
Novartis Pharmaceuticals

MVASI (bevacizumab-awwb)

VASCULAR ENDOTHELIAL GROWTH FACTOR(VEGF) MONOCLONAL ANTIBODY · METASTATIC COLORECTAL CANCER ·+5
AMGEN

ZIRABEV (bevacizumab-bvzr)

VASCULAR ENDOTHELIAL GROWTH FACTOR(VEGF) MONOCLONAL ANTIBODY · METASTATIC COLORECTAL CANCER ·+5
Parke-Davis Pfizer

ALYMSYS (bevacizumab-maly)

VASCULAR ENDOTHELIAL GROWTH FACTOR(VEGF) MONOCLONAL ANTIBODY · METASTATIC COLORECTAL CANCER ·+5
Amneal Pharmaceuticals

VEGZELMA (bevacizumab-adcd)

VASCULAR ENDOTHELIAL GROWTH FACTOR(VEGF) MONOCLONAL ANTIBODY · METASTATIC COLORECTAL CANCER ·+5
CELLTRION USA,

TORPENZ (everolimus)

ANTINEOPLASTIC - MTOR KINASE INHIBITORS · METASTATIC RENAL CELL CARCINOMA ·+6
Upsher-Smith Laboratories

EVEROLIMUS

ANTINEOPLASTIC - MTOR KINASE INHIBITORS · METASTATIC RENAL CELL CARCINOMA ·+6
NORTHSTAR RX LL

EVEROLIMUS

ANTINEOPLASTIC - MTOR KINASE INHIBITORS · METASTATIC RENAL CELL CARCINOMA ·+6
BIOCON PHARMA I

JOBEVNE (bevacizumab-nwgd)

VASCULAR ENDOTHELIAL GROWTH FACTOR(VEGF) MONOCLONAL ANTIBODY · METASTATIC COLORECTAL CANCER ·+5
BIOCON BIOLOGIC

AFINITOR (everolimus)

ANTINEOPLASTIC - MTOR KINASE INHIBITORS · METASTATIC RENAL CELL CARCINOMA ·+6
Novartis Pharmaceuticals

EVEROLIMUS

ANTINEOPLASTIC - MTOR KINASE INHIBITORS · METASTATIC RENAL CELL CARCINOMA ·+6
NOVUGEN PHARMA

ALYMSYS (bevacizumab-maly)

VASCULAR ENDOTHELIAL GROWTH FACTOR(VEGF) MONOCLONAL ANTIBODY · METASTATIC COLORECTAL CANCER ·+5
VALORUM BIOLOGI

YULITHIRA (everolimus)

ANTINEOPLASTIC - MTOR KINASE INHIBITORS · METASTATIC RENAL CELL CARCINOMA ·+6
CIVICASCRIPT, L